Insider Transactions in Q4 2022 at Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2022
|
Chris Senanayake Director |
SELL
Open market or private sale
|
Direct |
1,626
-36.81%
|
$1,626
$1.6 P/Share
|
|
Dec 29
2022
|
Steven M Richards Director |
SELL
Open market or private sale
|
Direct |
995
-36.82%
|
$995
$1.6 P/Share
|
|
Dec 29
2022
|
Milton Brown Director |
SELL
Open market or private sale
|
Direct |
995
-0.09%
|
$995
$1.6 P/Share
|
|
Dec 29
2022
|
William Adkins |
SELL
Open market or private sale
|
Direct |
995
-0.54%
|
$995
$1.6 P/Share
|
|
Dec 29
2022
|
Bette Jacobs Director |
SELL
Open market or private sale
|
Direct |
4,366
-12.27%
|
$4,366
$1.6 P/Share
|
|
Dec 29
2022
|
Mira Jung Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
328
-0.03%
|
$328
$1.6 P/Share
|
|
Dec 29
2022
|
Tyvin Rich Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,414
-36.79%
|
$1,414
$1.6 P/Share
|
|
Dec 29
2022
|
Anatoly Dritschilo CEO and Chairman |
SELL
Open market or private sale
|
Direct |
8,372
-0.77%
|
$8,372
$1.6 P/Share
|
|
Dec 29
2022
|
Peter Dritschilo President and COO |
SELL
Open market or private sale
|
Direct |
3,820
-36.8%
|
$3,820
$1.6 P/Share
|
|
Dec 29
2022
|
Hoek Michael Vander Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,243
-36.8%
|
$2,243
$1.6 P/Share
|